RxDoctor Payments Data

Charles Bratton, MD

Transplant Surgery · Loma Linda, CANPI 1982710869

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $621 and has fallen 80.6% since, to $121 in 2025. That places this record below the midpoint for transplant surgery clinicians in CA, where the typical reported total is $2,317.

$1,983in general payments, 2019–2025

Across 40 payments — averaging $49.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$427
  • Veloxis Pharmaceuticals, Inc.$400
  • Mallinckrodt Hospital Products Inc.$255
  • AbbVie$223
  • Paragonix Technologies, Inc.$154
  • Integra Lifesciences Corporation$98
  • plus $426 from 10 others

What the payments were for

  • Food & beverage$1,983100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,983 in reported general payments places this provider in the 45th percentile of 56 transplant surgery providers in California.

See all transplant surgery providers in California

Medicare billing

Part B allowed, 2024
$73,377
Medicare patients
35
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Valganciclovir Hcl169$22,288
Atovaquone17$12,061
Fluconazole94$3,725
Humalog Kwikpen U-100Insulin Lispro19$3,123
Insulin Lispro Kwikpen U-100Insulin Lispro20$2,964
Clotrimazole44$1,901
Ultra-Fine Nano Pen NeedlePen Needle, Diabetic26$1,615
Ursodiol22$939
Insulin Glargine-Yfgn11$865
Famotidine93$694
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim245$562
Unifine PentipsPen Needle, Diabetic16$536
Levetiracetam11$533
Nano 2nd Gen Pen NeedlePen Needle, Diabetic16$507
Pantoprazole Sodium87$505

Paid to pharmacies, not to this prescriber.

Other transplant surgery in Loma Linda

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →